Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 14, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details rather than financial performance metrics.
Material Changes and Transactions
The filing details specific share movements executed by the GlaxoSmithKline Employee Trust ("the GSK Trust") on behalf of employee incentive plans:
- February 12, 2007:
- Transferred 234,314 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Sold 3,323 Ordinary Shares for the SmithKline Beecham Mid-Term Incentive Plan at GBP 14.63 per share.
- Sold 784 Ordinary Shares for the SmithKline Beecham Mid-Term Incentive Plan at GBP 14.64 per share.
- Transferred 5,908 Ordinary Shares to participants in the SmithKline Beecham Mid-Term Incentive Plan.
- February 13, 2007:
- Transferred 319,678 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in shares held within the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory disclosure of specific share transactions.
Key Facts for Investor Verification
- Verify the total number of shares transferred to the Employee Share Option Plan 1991 (553,992 shares across two dates).
- Confirm the sale prices of GBP 14.63 and GBP 14.64 per share for the Mid-Term Incentive Plan transactions.
- Note that the GSK Trust is a discretionary trust for current and former employees, creating a potential interest for specific directors.
- Understand that this filing contains no financial performance data for the period.